Cost-Effectiveness Analysis of Lopinavir/Ritonavir Monotherapy Versus Standard Combination Antiretroviral Therapy in HIV-1 Infected Patients with Viral Suppression in France (ANRS 140 DREAM)

BACKGROUND: Protease inhibitor monotherapy is a simplified treatment strategy for virally suppressed HIV-positive patients that has the potential for cost savings, as fewer drugs are used than with combination therapy. However, evidence for its economic value is limited. OBJECTIVES: We assessed the...

Descripción completa

Detalles Bibliográficos
Autores principales: Garay, Osvaldo Ulises, Nishimwe, Marie Libérée, Bousmah, Marwân-al-Qays, Janah, Asmaa, Girard, Pierre-Marie, Chêne, Geneviève, Moinot, Laetitia, Sagaon-Teyssier, Luis, Meynard, Jean-Luc, Spire, Bruno, Boyer, Sylvie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2019
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6861410/
https://www.ncbi.nlm.nih.gov/pubmed/30968368
http://dx.doi.org/10.1007/s41669-019-0130-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6861410/
https://www.ncbi.nlm.nih.gov/pubmed/30968368
http://dx.doi.org/10.1007/s41669-019-0130-7

Ejemplares similares